SELLAS Life Sciences Group, Inc. (SLS)
11.74
+0.41
(+3.62%)
USD |
NASDAQ |
Oct 02, 16:00
11.75
+0.01
(+0.09%)
After-Hours: 20:00
SELLAS Life Sciences Group Price to Book Value : 17.22 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 17.22 |
| October 01, 2026 | 16.62 |
| September 30, 2026 | 18.06 |
| September 29, 2026 | 16.88 |
| September 28, 2026 | 17.00 |
| September 25, 2026 | 17.03 |
| September 24, 2026 | 17.57 |
| September 23, 2026 | 16.90 |
| September 22, 2026 | 17.63 |
| September 21, 2026 | 16.68 |
| September 18, 2026 | 16.85 |
| September 17, 2026 | 16.91 |
| September 16, 2026 | 17.10 |
| September 15, 2026 | 16.56 |
| September 14, 2026 | 17.20 |
| September 11, 2026 | 16.93 |
| September 10, 2026 | 19.79 |
| September 09, 2026 | 20.46 |
| September 08, 2026 | 20.48 |
| September 04, 2026 | 20.33 |
| September 03, 2026 | 20.10 |
| September 02, 2026 | 20.77 |
| September 01, 2026 | 19.39 |
| August 31, 2026 | 19.57 |
| August 28, 2026 | 19.38 |
| Date | Value |
|---|---|
| August 27, 2026 | 22.31 |
| August 26, 2026 | 20.14 |
| August 25, 2026 | 20.67 |
| August 24, 2026 | 21.01 |
| August 21, 2026 | 22.68 |
| August 20, 2026 | 19.66 |
| August 19, 2026 | 20.32 |
| August 18, 2026 | 19.22 |
| August 17, 2026 | 19.07 |
| August 14, 2026 | 18.75 |
| August 13, 2026 | 18.13 |
| August 12, 2026 | 17.26 |
| August 11, 2026 | 16.21 |
| August 10, 2026 | 16.19 |
| August 07, 2026 | 17.62 |
| August 06, 2026 | 17.16 |
| August 05, 2026 | 17.40 |
| August 04, 2026 | 17.32 |
| August 03, 2026 | 16.46 |
| July 31, 2026 | 14.68 |
| July 30, 2026 | 15.09 |
| July 29, 2026 | 14.82 |
| July 28, 2026 | 14.80 |
| July 27, 2026 | 15.89 |
| July 24, 2026 | 16.60 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Capricor Therapeutics, Inc. | 2.112 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Incyte Corp. | 3.652 |
| Insmed, Inc. | 32.02 |
Price to Book Value Related Metrics
| Price | 11.74 |
| Earnings Yield | -1.81% |
| Market Cap | 2.371B |